好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Lesion Network Mapping Study of the Cerebellar Lesion-related Impulsivity and Compulsivity
General Neurology
S32 - General Neurology 1 (4:06 PM-4:18 PM)
004

Emerging evidence positions that cerebellar lesions cause impulsivity and compulsivity. However, whether these lesions alone trigger these behaviors or their connections with other brain areas are responsible remains unclear. Our study dives into these compelling questions to uncover the cerebellum and it's cerebello-cerebral connectivity related impulsive and compulsive symptoms.

The cerebellum functions as a critical hub within brain networks governing motor, cognitive-affective, and reward processes. The evolutionarily expanded posterior cerebellum supports cognitive operations. Recent evidence reveals that impulsivity and compulsivity are clinical features in cerebellar ataxia patients. These findings establish the cerebellum's previously underrecognized role in regulating impulsive and compulsive behaviors.

We conducted a cross-sectional, observational lesion-symptom network mapping (LNM) study involving 36 patients with focal cerebellar lesions. Participants underwent comprehensive evaluations using validated instruments, including the Scale for the Assessment and Rating of Ataxia (SARA), the Cerebellar Cognitive Affective Syndrome Scale (CCAS), and the Cerebellar Impulsivity-Compulsivity Assessment (CIA). LNM utilized human connectome data (n=1,000) to delineate cerebello-cerebral connectivity profiles, which compared between patients exhibiting high versus low levels CIA to elucidate the neural underpinnings of these behavioral traits.

We showed that lesions associated with higher CIA scores were predominantly localized to the right cerebellar hemisphere, with significant involvement of lobule VI, Crus I-II. LNM results demonstrated that patients with elevated CIA scores displayed enhanced connectivity between the right cerebellar hemisphere and left frontal cortical regions, including the inferior/medial frontal gyrus, caudate nucleus, and angular gyrus. Conversely, these patients exhibited reduced connectivity between the right and left cerebellar hemispheres, specifically involving lobules III–V, Crus I–II, and lobules VII–IX.

The observed cerebello-cerebral connectivity patterns delineate critical neural circuits implicated in the manifestation of impulsive and compulsive behaviors following focal cerebellar injury. Our findings suggest that targeting fronto-cerebellar connectivity through neuromodulation strategies could represent a therapeutic approach for mitigating impulsivity and compulsivity.

Authors/Disclosures
Yicheng Lin, MD (Taipei Veterans General Hospital)
PRESENTER
Dr. Lin has nothing to disclose.
Zhelong Liu, MD Dr. Liu has nothing to disclose.
Chi-Ying (Roy) Lin, MD, FAAN (Baylor College of Medicine) Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Luciana Salama, MD Dr. Salama has nothing to disclose.
Veronica E. Navarrine Nasjleti, Medical Student Dr. Navarrine Nasjleti has nothing to disclose.
SANTIAGO J. VOLMARO, MS Mr. VOLMARO has nothing to disclose.
Eunice Chang, PhD Dr. Chang has received personal compensation for serving as an employee of PHAR (now ADVI).
Ching-Po Lin (National Yang Ming Chiao Tung University) No disclosure on file
Hernan Chaves, MD Mr. Chaves has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelai.
Maria Eugenia Sarandria (FLENI) Maria Eugenia Sarandria has nothing to disclose.
Zoe Ziperovich, Student Miss Ziperovich has nothing to disclose.
Adrian M. Kim, Jr. Mr. Kim has nothing to disclose.
Florencia Yorio No disclosure on file
Ramiro Salas (Baylor College of Medicine) The institution of Ramiro Salas has received research support from VHA. The institution of Ramiro Salas has received research support from Wallace foundation.
ALEJANDRO D. MUGGERI, Sr., MD Dr. MUGGERI has nothing to disclose.
Virginia A. Pujol Lereis, MD (FLENI) Dr. Pujol Lereis has nothing to disclose.
BLANCA D. DIEZ, MD Dr. DIEZ has nothing to disclose.
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Ming-Kai Pan, MD, PhD The institution of Dr. Pan has received research support from National Science and Technology Council.
Andrés P. Varani, Sr., PhD Dr. Varani has nothing to disclose.
Sheng-Han Kuo, MD, FAAN (Columbia University) Dr. Kuo has nothing to disclose.
Malco D. Rossi, MD (FLENI) Dr. Rossi has nothing to disclose.